Provided herein are antibacterial compounds, wherein the compounds in some embodiments have broad spectrum bioactivity. The compounds provided herein can in other embodiments overcome the resistance conferred by single amino acid mutations at defined positions of bacterial Signal Peptidases (SPases) and in other embodiments provide for a broad spectrum of antibiotic bioactivity. Pharmaceutical compositions and methods for treatment using the compounds described herein are also provided.
作者:CHAMPSEIX, A.、CHANET, J.、ETIENNE, A.、LE, BERRE, A.、MASSON, J. C.、NAPIERAL+
DOI:——
日期:——
MACROCYCLIC BROAD SPECTRUM ANTIBIOTICS
申请人:RQX PHARMACEUTICALS, INC.
公开号:US20170088582A1
公开(公告)日:2017-03-30
Provided herein are antibacterial compounds, wherein the compounds in some embodiments have broad spectrum bioactivity. In various embodiments, the compounds act by inhibition of bacterial type 1 signal peptidase (SpsB), an essential protein in bacteria. Pharmaceutical compositions and methods for treatment using the compounds described herein are also provided.
Champseix, A.; Chanet, J.; Etienne, A., Bulletin de la Societe Chimique de France, 1985, # 3, p. 463 - 472
作者:Champseix, A.、Chanet, J.、Etienne, A.、Berre, A. Lemasson, J. C.、Napierala, C.、Vessiere, R.